Tempus AI (TEM) Stock Surges as FDA Approves AI-Powered Heart Disease Detection Tool

Tempus AI (TEM) wins FDA clearance for ECG-PH, an AI-driven tool detecting pulmonary hypertension from standard ECGs—its third cardiac software approval.

The post Tempus AI (TEM) Stock Surges as FDA Approves AI-Powered Heart Disease Detection Tool appeared first on Blockonomi.